Pepti Review: GLP-1 Pricing, Included Care, and Limitations

Pepti lists compounded semaglutide at $99 a month and tirzepatide at $159 a month, with physician review, ongoing care, shipping, and messaging included. It says there is no separate membership, consultation, or visit fee. Those clear inclusions make the advertised package easy to compare, provided the written quote for your prescription matches it.¹

This review uses public company information read in October 2026. We have not received treatment or tested its medication, and the quoted service terms are company statements.

What is included in the program?

Pepti's published GLP-1 answers describe a monthly medication service with a clinician's review and continuing support. The site says the refill price stays the same and quotes the same price in every state. Those are useful promises to retain in your order documents, particularly if your dose or treatment changes later.¹

Before enrolling, ask what ongoing care means in practice. Is support limited to messaging, are scheduled visits available, and who handles urgent questions? A package can include communication without specifying how quickly a clinician will respond. Your decision should reflect the level of contact you need, especially when starting or adjusting treatment.

What does Pepti cost?

At the advertised monthly prices, twelve uninterrupted purchases would cost $1,188 for semaglutide or $1,908 for tirzepatide. This is simple arithmetic from the published rates, not a promise of eligibility or a personalized annual treatment plan.¹

Check whether each purchase covers a calendar month or a four-week supply. Over a year, thirteen four-week supplies cover 52 weeks; twelve cover only 48. Also confirm how much medication is dispensed, the refill date, and what happens if a clinician changes the dose. A flat price is useful only when the amount and billing period are clear.

What are the main strengths and limitations?

The strengths are the visible medication-specific prices and a published list of included services. The important limitations are what those prices cannot establish: dispensing quality, suitability, individual results, or the quality of follow-up. Request the pharmacy name for your own prescription and verify instructions for the concentration and syringe supplied.

FDA's concerns about compounded GLP-1 treatment include dosing errors, quality, and products that have not undergone the agency's approval review. A licensed clinician and a low quoted cost do not make a compounded product equivalent to an approved medicine.²

Pepti's wider catalog is a separate consideration. Do not assume that evidence for an approved GLP-1 medicine supports another peptide or a combination offered on the same site. Each proposed treatment needs an explanation of its purpose, evidence, and risks.

Who might consider it?

Pepti may suit a patient who is already discussing compounded care with a clinician and wants a published monthly package without a separate advertised membership fee. It is a less comfortable fit if you require an approved branded product, extensive scheduled visits, or answers about fulfillment that you have not yet obtained.

Our assessment

The published offer gives shoppers a useful price to investigate. Confirm the billing period, pharmacy, cancellation deadline, and refill process in writing before deciding. Compare the full terms with other semaglutide programs and tirzepatide programs. If digestive symptoms are your main concern, read our guide to probiotics during GLP-1 treatment and bring the relevant questions to your prescriber.